Navigation Links
Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
Date:10/26/2007

ts, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process and the commercialization of the Company's products thereafter, if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. International Conference On Malaria - Laveran To Genomics
2. African Conference to Combat AIDS
3. International conference on Ayurveda to be held on Kerala
4. 5th European Breast Cancer Conference Talks about Everything from Patient to Oncologist
5. Consultation Conference to control HIV, TB and Malaria
6. Afghanistan Hosting A UN Funded Regional Health Conference
7. New Delhi to Host Conference on Accident & Emergency Medical Treatment
8. UN Conference Calls For Monitoring System To Check Bird Flu
9. Fourth international urogynaecology conference on Jun 16
10. National Autism Conference In US Expected To Draw Thousands In Attendance
11. Ayurvedic Treatment to be Focus of Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Within3 Expands into Mobile Applications 2VoiceNation Calls on TASterix as Their CRM Solution 61493 1VoiceNation Calls on TASterix as Their CRM Solution 61493 2New York Personal Injury Law Firm Cellino 26amp 3B Barnes Wins 243 25 Million Settlement For Workers Injured in Truck Accident 61488 1New York Personal Injury Law Firm Cellino 26amp 3B Barnes Wins 243 25 Million Settlement For Workers Injured in Truck Accident 61488 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 1New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 4